ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding ImageneBio, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 70 | 1 | 57 | −12 |
| Shares | 29.0M | 354.8K | 28.4M | −246.0K (−0.9%) |
| Value | $47.9M | $585.5K | $49.1M | +$1.86M (+3.9%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held ImageneBio, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 352,176 | $609.3K | 0.00% |
| FNY Investment Advisers, LLC | 231,383 | $400.0K | 0.19% |
| Vazirani Asset Management LLC | 115,668 | $200.1K | 0.36% |
| Prelude Capital Management, LLC | 50,638 | $87.6K | 0.01% |
| LPL Financial LLC | 12,000 | $20.8K | 0.00% |
| Advisor Group Holdings, Inc. | 1,503 | $2.60K | 0.00% |
Sold out (18)
Institutions that held ImageneBio, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Verition Fund Management LLC | 135,297 | $223.2K |
| Centiva Capital, LP | 73,431 | $121.2K |
| Alpine Global Management, LLC | 64,641 | $106.7K |
| Y-Intercept (Hong Kong) Ltd | 60,628 | $100.0K |
| Marshall Wace, LLP | 44,933 | $74.1K |
| Paloma Partners Management Co | 30,240 | $49.9K |
| Virtu Financial LLC | 28,053 | $46.0K |
| Squarepoint Ops LLC | 27,666 | $45.6K |
| HRT Financial LP | 26,893 | $44.0K |
| AQR Capital Management LLC | 21,861 | $36.1K |
| XTX Topco Ltd | 16,607 | $27.4K |
| Mirae Asset Global ETFs Holdings Ltd. | 16,270 | $26.8K |
| Citigroup Inc | 5,005 | $8.26K |
| Cubist Systematic Strategies, LLC | 4,842 | $7.99K |
| Rhumbline Advisers | 3,856 | $6.36K |
| Macquarie Group Ltd | 1,585 | $2.62K |
| CWM, LLC | 985 | $2.00K |
| New York State Common Retirement Fund | 283 | $467 |
Not filed for Q3 2024 yet (1)
Institutions that held ImageneBio, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 354,842 | $585.5K |